![](https://investorshub.advfn.com/uicon/17484.png?cb=1489146554)
Tuesday, March 06, 2018 10:29:07 AM
confusion with 2 names entirely different from one another. Also hard to confuse one product (Diabecline) that was discontinued because of product failure, and one that works and ascending (Vitastem). A cynical person might think the trademark owner of the failed product is trying to interfere in the sales and ownership of the working and ascending product. With no IP ownership of anything involved here. Kind of like a poster here suing Chris on infringement, with as much IP as the said trademark owner.
All information provided is the opinion of this poster from review of information in the public domain.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM